Healthspan Biotech Pre-Seed Funding Round

Healthspan Biotech is a preclinical biopharmaceutical company dedicated to advancing healthspan and longevity research. The company's core focus is on slowing epigenetic aging and delaying the onset of age-related diseases. Their lead compound is designed to address a broad spectrum of critical pathways implicated in aging, including inflammation, the gut microbiome, AMPK, Nrf2, and longevity genes. Healthspan Biotech is currently seeking $500,000 USD in a pre-seed funding round to validate their compound's efficacy through proof-of-concept studies in various animal models of disease. This investment represents an opportunity to support cutting-edge research in a rapidly growing field.